Bibliografie tematiche / Enzyme activation / Libri

Libri sul tema "Enzyme activation"

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Enzyme activation.
Autore: Grafiati
Pubblicato: 4 giugno 2021
Ultima modifica: 5 marzo 2023

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 libri per l'attività di ricerca sul tema "Enzyme activation".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

Ottaway, J. H. Regulation of enzyme activity. Oxford: IRL Press, 1988.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

H, Stenmark, a cura di. Phosphoinositides in subcellular targeting and enzyme activation. Berlin: Springer, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Stein, Ross L. Kinetics of enzyme action: Essential principles for drug hunters. Hoboken, N.J: John Wiley, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Stenmark, Harald, a cura di. Phosphoinositides in Subcellular Targeting and Enzyme Activation. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18805-3.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Krupi͡anko, V. I. Vektornyĭ metod predstavlenii͡a fermentativnykh reakt͡siĭ. Moskva: "Nauka", 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Alan, Wiseman, a cura di. Enzyme induction, mutagen activation, and carcinogen testing in yeast. Chichester, West Sussex, England: E. Horwood, 1987.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

H, Schmid-Schönbein, Wurzinger L. J, Zimmermann R. E e Commission of the European Communities. Committee on Medical and Public Health Research., a cura di. Enzyme activation in blood-perfused artificial organs: Proceedings of an interdisciplinary meeting. Boston: Nijhoff, 1985.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Mordechai, Liscovitch, a cura di. Signal-activated phospholipases. Austin: R.G. Landes Co., 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Akira, Arimura, Saʻīd Sāmī e International Symposium on VIP, PACAP, and Related Peptides (2nd : 1995 : New Orleans, La.), a cura di. VIP, PACAP, and related peptides: Second international symposium. New York: New York Academy of Sciences, 1996.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Light, P. E. An investigation into factors controlling activation of the enzyme protein Kinase C in the regulation of neurotransmitter release at the frog neuromuscular junction. Birmingham: University of Birmingham, 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Chen, Chang-Hwei. Activation and Detoxification Enzymes. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1049-2.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

1923-, Lorand Laszlo, e Mann Kenneth G, a cura di. Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. San Diego: Academic Press, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Rossomando, Edward F. HPLC in enzymatic analysis. 2a ed. New York: Wiley, 1998.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

M, Cunningham Fiona, a cura di. Lipid mediators. London: Academic Press, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

C, Murphy Robert, e Fitzpatrick Frank A, a cura di. Arachidonate related lipid mediators. San Diego: Academic Press, 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

L, Schramm Vern, e Purich Daniel L, a cura di. Enzyme kinetics and mechanism. 1999.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Enzyme kinetics and mechanism. San Diego: Academic Press, 2002.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Stein, Ross L. Kinetics of Enzyme Action. Wiley & Sons, Incorporated, John, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Stenmark, Harald. Phosphoinositides in Subcellular Targeting and Enzyme Activation. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Stein, Ross L. Kinetics of Enzyme Action: Essential Principles for Drug Hunters. Wiley & Sons, Incorporated, John, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Stein, Ross L. Kinetics of Enzyme Action: Essential Principles for Drug Hunters. Wiley & Sons, Incorporated, John, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Stein, Ross L. Kinetics of Enzyme Action: Essential Principles for Drug Hunters. Wiley & Sons, Incorporated, John, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Stenmark, Harald. Phosphoinositides in Subcellular Targeting and Enzyme Activation. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Stenmark, Harald. Phosphoinositides in Subcellular Targeting and Enzyme Activation. Springer, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Engel, P. C. Enzymology LabFax (Labfax Series). Academic Press, 1996.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Baici, Antonio. Kinetics of Enzyme-Modifier Interactions: Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms. Baici Antonio, 2015.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Baici, Antonio. Kinetics of Enzyme-Modifier Interactions: Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms. Springer, 2016.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Baici, Antonio. Kinetics of Enzyme-Modifier Interactions: Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms. Springer London, Limited, 2015.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Activation And Detoxification Enzymes Functions And Implications. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Cooper, A. The Enzyme Catalysis Process:Energetics, Mechanism and Dynamics. Springer, 1989.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Cascorbi, Ingolf. Polymorphic cytochrome P450 2D6 as the responsible enzyme of activation. A cura di Paul Farquhar-Smith, Pierre Beaulieu e Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0079.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
The landmark paper discussed in this chapter is ‘Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)’, published by Dayer et al. in 1988. Codeine is an old but frequently prescribed drug used for the treatment of mild-to-moderate pain. However, its use is nowadays restricted after observations of partly fatal respiratory repression in children. Codeine itself exhibits no analgesic effect, but is partly activated by O-demethylation to morphine by cytochrome P450 2D6 (CYP2D6). The identification of the polymorphic CYP2D6 as the enzyme responsible for activation was achieved by Dayer et al. in 1998 and was an important milestone contributing to the widely observed inter-individual differences of drug action and side effects of codeine. Translating the pharmacogenetics of codeine into clinical practice is currently underway in clinical trials, to identify ineffective analgesics and, in particular, avoid severe adverse events.
32

Soda, Kenji, e Toshio Fukui. Molecular Aspects of Enzyme Catalysis. Wiley & Sons, Incorporated, John, 2008.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Molecular aspects of enzyme catalysis. Tokyo: Kodansha, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Fukui, Tukui, e Kenji Soda. Molecular Aspects of Enzyme Catalysis. Vch Pub, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

Soda, Kenji, e Toshio Fukui. Molecular Aspects of Enzyme Catalysis. Wiley & Sons, Limited, John, 2007.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Lyle, Stephen. The sulfate-activation pathway: A bifunctional enzyme which utilizes intermediate channeling. 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Clarke, Andrew. Temperature and reaction rate. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780199551668.003.0007.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
All other things being equal, physiological reaction rate increases roughly exponentially with temperature. Organisms that have adapted over evolutionary time to live at different temperatures can have enzyme variants that exhibit similar kinetics at the temperatures to which they have adapted to operate. Within species whose distribution covers a range of temperatures, there may be differential expression of enzyme variants with different kinetics across the distribution. Enzymes adapted to different optimum temperatures differ in their amino acid sequence and thermal stability. The Gibbs energy of activation tends to be slightly lower in enzyme variants adapted to lower temperatures, but the big change is a decrease in the enthalpy of activation, with a corresponding change in the entropy of activation, both associated with a more open, flexible structure. Despite evolutionary adjustments to individual enzymes involved in intermediary metabolism (ATP regeneration), many whole-organism processes operate faster in tropical ectotherms compared with temperate or polar ectotherms. Examples include locomotion (muscle power output), ATP regeneration (mitochondrial function), nervous conduction and growth.
38

Brown, Stephanie Leanne. The biosynthesis of poly (ribitol-phosphate) wall teichoic acids and the roles of individual tailoring modifications. 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Smerage, Jeffrey. Activated Transcription of the Glycolytic Enzyme Genes of Saccharomyces Cerevisiae: The Chromatin Structures of TP11 and Mechanisms of RAP1P Mediated Activation. Dissertation Discovery Company, 2018.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Smerage, Jeffrey. Activated Transcription of the Glycolytic Enzyme Genes of Saccharomyces Cerevisiae: The Chromatin Structures of TP11 and Mechanisms of RAP1P Mediated Activation. Creative Media Partners, LLC, 2018.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Chen, Chang-Hwei. Activation and Detoxification Enzymes: Functions and Implications. Springer, 2014.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Chen, Chang-Hwei. Activation and Detoxification Enzymes: Functions and Implications. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Deegan, Patrick. Porphyria. A cura di Patrick Davey e David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0179.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
This chapter discusses six diseases caused by inborn errors of metabolism affecting the biosynthesis of haem. Haem is a tetracyclic metal-binding compound involved in oxygen transport (in haemoglobin and myoglobin) and redox reactions (e.g. in the cytochrome P450 system). Each of these conditions is caused by a single gene defect in one of the enzymes involved in the biosynthesis of haem. Inheritance is usually autosomal dominant with incomplete penetrance. The enzyme defect results in disease, not as a result of deficiency of the reaction product, but as a result of accumulation of precursors. Early, soluble precursors, 5-aminolaevulinic acid, and porphobilinogen (not porphyrins as such) are neurotoxic and, when present in great excess, as occurs when flux through the haem synthetic pathway is increased in response to particular medications or hormones, lead to acute neurovisceral crises. Later cyclical precursors (porphyrins) in the pathway are also water soluble and excreted in urine, but are susceptible to activation by electromagnetic radiation in the visible spectrum and are converted to free-radical metabolites that cause pain, inflammation, and tissue damage in the skin. The final haem precursors (also porphyrins) are hydrophobic and excreted in the bile and faeces and are also activated by light to toxic metabolites.
44

O’Neal, M. Angela. Pain in the Back. A cura di Angela O’Neal. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190609917.003.0006.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
This case explores how bone health can be affected by antiepileptic drugs (AEDs), and why this is an important issue in women with epilepsy (WWE). AEDs affect bone health through activation of the cytochrome P450 system in the liver, leading to increased metabolism of vitamin D. The enzyme-inducing AEDs include phenytoin, carbamazepine, phenobarbital, and primidone. Risk factors for osteoporosis include female gender, low body mass, inadequate vitamin D intake, and smoking. The specific AEDs used and the length of treatment confer additional risks. Furthermore, in WWE, risks are magnified related to falls, either from seizures or related to medication toxicity. Screening with bone density and measures to promote bone health are extremely important in these at-risk women.
45

Hester, Charles K. Mitogen-Activated Protein Kinases: Activation, Functions and Regulation. Nova Science Publishers, Incorporated, 2019.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

Rossomando, Edward F. HPLC in Enzymatic Analysis. Wiley & Sons, Incorporated, John, 2009.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Frenkel, Joost, e Hans R. Waterham. Mevalonate Kinase Deficiency. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0039.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
Mevalonate kinase deficiency (MKD) is an autosomal recessive inborn error of isoprenoid biosynthesis, a pathway yielding sterols and nonsterol isoprenoids.In patients, the enzyme activity of mevalonate kinase is severely reduced due to mutations in the encoding gene, MVK. The substrate, mevalonate, accumulates and is elevated in blood and urine. Shortage of certain downstream products of the pathway, nonsterol isoprenoids, leads to dysregulation of the innate immune system, activation of inflammasomes, and interleukin (IL)-1 mediated inflammation.Symptoms start in early childhood with recurrent attacks of fever, vomiting, diarrhea, headache, sore throat, abdominal pain, arthralgias, painful lymphadenopathy, hepatosplenomegaly, skin rash, and mucosal ulcers. Severely affected patients have additional symptoms, such as intellectual impairment, progressive cerebellar ataxia, and tapetoretinal degeneration. Complications include intestinal obstruction, AA-amyloidosis, hemophagocytosis, and severe infection.Management of MKD is directed at controlling inflammation.
48

(Editor), John N. Abelson, Melvin I. Simon (Editor), Laszlo Lorand (Editor) e Kenneth G. Mann (Editor), a cura di. Proteolytic Enzymes in Coagulation, Fibrinolysis, and Complement Activation, Part B, Volume 223: Volume 223: Proteolytic Enzymes in Coagulation, Fibrinolysis ... Activation Part B (Methods in Enzymology). Academic Press, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Rider, Lisa G., e Frederick W. Miller. Outcome assessment in the idiopathic inflammatory myopathies. A cura di Hector Chinoy e Robert Cooper. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754121.003.0016.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Abstract (sommario):
Due to their rarity, heterogeneity, and multispecialty nature, the myositis syndromes have limited data-driven consensus on appropriate outcome measures. Recently, two international, multispecialty consortia developed new tools and consensus on core set measures of myositis disease activity and damage, as well as response criteria that are now recommended for use as clinical trial endpoints but will also be useful in clinical practice. Magnetic resonance imaging, muscle ultrasound, selected laboratory tests, and immunological biomarkers—including cytokines, chemokines, lymphocyte flow cytometry, and endothelial activation markers—can all be helpful adjuncts to serum muscle enzyme levels in assessing disease activity and damage, but these have not yet been fully validated. Definitions of clinically inactive disease, complete clinical response, and remission have also been proposed but require further validation. These advances should enhance the development of therapies by standardizing our ability to demonstrate their efficacy in treating the idiopathic inflammatory myopathies.
50

Abelson, John N., Laszlo Lorand, Melvin I. Simon e Kenneth G. Mann. Proteolytic Enzymes in Coagulation, Fibrinolysis, and Complement Activation, Part B. Elsevier Science & Technology Books, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Ti possono interessare anche gli elenchi di altri tipi di fonti sul tema "Enzyme activation":
Articoli di riviste Tesi

Vai alla bibliografia